{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T18:10:36Z","timestamp":1783361436781,"version":"3.54.6"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["2I01CX000920-04"],"award-info":[{"award-number":["2I01CX000920-04"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajicjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ajic.2022.06.019","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T19:08:35Z","timestamp":1656184115000},"page":"434-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence and characteristics of multidrug-resistant Escherichia coli sequence type ST131 at two academic centers in Boston and Minneapolis, USA"],"prefix":"10.1016","volume":"51","author":[{"given":"M\u00e9lanie T.","family":"Mahoney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter V.","family":"Brigman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7347-9276","authenticated-orcid":false,"given":"Brian D.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9588-5045","authenticated-orcid":false,"given":"James R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0462-0421","authenticated-orcid":false,"given":"Elizabeth B.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2022.06.019_bib0001","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3201\/eid1402.070350","article-title":"Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15","volume":"14","author":"Coque","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ajic.2022.06.019_bib0002","doi-asserted-by":"crossref","first-page":"dlab092","DOI":"10.1093\/jacamr\/dlab092","article-title":"Extended-spectrum beta-lactamases: an update on their characteristics, epidemiology and detection","volume":"3","author":"Castanheira","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.ajic.2022.06.019_bib0003","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1128\/AAC.00048-15","article-title":"Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations","volume":"59","author":"Drawz","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2022.06.019_bib0004","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1086\/653932","article-title":"Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States","volume":"51","author":"Johnson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2022.06.019_bib0005","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12879-022-07167-y","article-title":"A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011-2020","volume":"22","author":"Dunne","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ajic.2022.06.019_bib0006","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jac\/dkm464","article-title":"Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15","volume":"61","author":"Nicolas-Chanoine","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2022.06.019_bib0007","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/jac\/dkw133","article-title":"CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain","volume":"71","author":"Merino","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2022.06.019_bib0008","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/infdis\/jis933","article-title":"Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli","volume":"207","author":"Johnson","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajic.2022.06.019_bib0009","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1128\/AAC.01604-13","article-title":"Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-beta-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010","volume":"57","author":"Banerjee","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2022.06.019_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00377-13","article-title":"The epidemic of extended-spectrum-beta-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx","volume":"4","author":"Price","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.ajic.2022.06.019_bib0011","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1073\/pnas.1322678111","article-title":"Global dissemination of a multidrug resistant Escherichia coli clone","volume":"111","author":"Petty","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajic.2022.06.019_bib0012","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/jac\/dkv017","article-title":"CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic","volume":"70","author":"Matsumura","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2022.06.019_bib0013","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1093\/jac\/dky296","article-title":"Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe","volume":"73","author":"Merino","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2022.06.019_bib0014","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fcimb.2020.00125","article-title":"High prevalence of ST131 subclades C2-H30Rx and C1-M27 among extended-spectrum beta-lactamase-producing Escherichia coli causing human extraintestinal infections in patients from two hospitals of Spain and France During 2015","volume":"10","author":"Flament-Simon","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ajic.2022.06.019_bib0015","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/jac\/dkaa069","article-title":"Emergence of CTX-M-27-producing Escherichia coli of ST131 and clade C1-M27 in an impacted ecosystem with international maritime traffic in South America","volume":"75","author":"Fernandes","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2022.06.019_bib0016","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s40265-019-01180-3","article-title":"Extended-spectrum beta-lactamase-producing Enterobacteriaceae: update on molecular epidemiology and treatment options","volume":"79","author":"Peirano","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ajic.2022.06.019_bib0017","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1128\/AAC.00666-12","article-title":"Prevalence and molecular characterization of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in a pediatric patient population","volume":"56","author":"Chandramohan","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2022.06.019_bib0018","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/cid\/ciy363","article-title":"Colonization with levofloxacin-resistant extended-spectrum beta-lactamase-producing Enterobacteriaceae and risk of bacteremia in hematopoietic stem cell transplant recipients","volume":"67","author":"Satlin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2022.06.019_bib0019","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1007\/s10096-021-04256-9","article-title":"Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, blaCTX-M genotype, and resistance to comparator agents","volume":"40","author":"Johnston","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ajic.2022.06.019_bib0020","doi-asserted-by":"crossref","first-page":"ofw138","DOI":"10.1093\/ofid\/ofw138","article-title":"The niche for Escherichia coli sequence type 131 among veterans: urinary tract abnormalities and long-term care facilities","volume":"3","author":"Drekonja","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ajic.2022.06.019_bib0021","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/cid\/ciu864","article-title":"Emerging Escherichia coli O25b\/ST131 clone predicts treatment failure in urinary tract infections","volume":"60","author":"Can","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2022.06.019_bib0022","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ijantimicag.2015.08.012","article-title":"Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates","volume":"46","author":"Hirsch","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ajic.2022.06.019_bib0023","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-eighth informational supplement. M100-S28","year":"2018"},{"key":"10.1016\/j.ajic.2022.06.019_bib0024","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1128\/AAC.02961-15","article-title":"Susceptibility of multidrug-resistant Gram-negative urine isolates to oral antibiotics","volume":"60","author":"Hirsch","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2022.06.019_bib0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/1758-2229.12019","article-title":"The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups","volume":"5","author":"Clermont","year":"2013","journal-title":"Environ Microbiol Rep"},{"key":"10.1016\/j.ajic.2022.06.019_bib0026","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/AAC.00297-09","article-title":"Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004","volume":"53","author":"Johnson","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2022.06.019_bib0027","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/cid\/cit503","article-title":"Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans","volume":"57","author":"Colpan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2022.06.019_bib0028","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00732-17","article-title":"Epidemic emergence in the United States of Escherichia coli sequence type 131-H30 (ST131-H30), 2000 to 2009","volume":"61","author":"Johnson","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2022.06.019_bib0029","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3201\/eid2305.161865","article-title":"CTX-M-27-producing Escherichia coli of sequence type 131 and clade C1-M27, France","volume":"23","author":"Birgy","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ajic.2022.06.019_bib0030","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01064-22","article-title":"Novel multiplex PCR method and genome sequence-based analog for high-resolution subclonal assignment and characterization of Escherichia coli sequence type 131 isolates","author":"Johnston","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ajic.2022.06.019_bib0031","first-page":"161","article-title":"Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals","volume":"209","author":"Saladin","year":"2002","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ajic.2022.06.019_bib0032","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1128\/AAC.05824-11","article-title":"Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-beta-lactamase-producing E. coli from the United States, 2000 to 2009","volume":"56","author":"Johnson","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2022.06.019_bib0033","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1128\/IAI.06388-11","article-title":"Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype","volume":"80","author":"Johnson","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.ajic.2022.06.019_bib0034","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1128\/AAC.01065-13","article-title":"The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics","volume":"57","author":"Banerjee","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2022.06.019_bib0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/mdr.2014.0070","article-title":"High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic","volume":"21","author":"Papagiannitsis","year":"2015","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ajic.2022.06.019_bib0036","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/669865","article-title":"Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts","volume":"34","author":"Banerjee","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2022.06.019_bib0037","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1017\/ice.2017.156","article-title":"Incidence of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella infections in the United States: a systematic literature review","volume":"38","author":"McDanel","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2022.06.019_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220265","article-title":"The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017","volume":"14","author":"Critchley","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ajic.2022.06.019_bib0039","doi-asserted-by":"crossref","DOI":"10.3201\/eid2209.160148","article-title":"Fluoroquinolone-resistant and extended-spectrum beta-lactamase-producing Escherichia coli infections in patients with pyelonephritis, United States","volume":"22","author":"Talan","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ajic.2022.06.019_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017402","article-title":"Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis","volume":"7","author":"Kardas-Sloma","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajic.2022.06.019_bib0041","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ijantimicag.2016.09.023","article-title":"Trends of extended-spectrum beta-lactamase-producing Escherichia coli sequence type 131 and its H30 subclone in a French hospital over a 15-year period","volume":"48","author":"Sauget","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ajic.2022.06.019_bib0042","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00825-21","article-title":"Detection of CTX-M-27 beta-lactamase genes on two distinct plasmid types in ST38 Escherichia coli from three U.S. states","volume":"65","author":"Cameron","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2022.06.019_bib0043","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01664-18","article-title":"Rapid emergence, subsidence, and molecular detection of Escherichia coli sequence type 1193-fimH64, a new disseminated multidrug-resistant commensal and extraintestinal pathogen","volume":"57","author":"Johnson","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ajic.2022.06.019_bib0044","doi-asserted-by":"crossref","first-page":"E497","DOI":"10.1111\/j.1469-0691.2012.03999.x","article-title":"Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre","volume":"18","author":"Adler","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ajic.2022.06.019_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.887799","article-title":"Bacteriophage cocktail and microcin-producing probiotic Escherichia coli protect mice against gut colonization with multidrug-resistant Escherichia coli sequence type 131","volume":"13","author":"Porter","year":"2022","journal-title":"Front Microbiol"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655322005041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655322005041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:34:44Z","timestamp":1759300484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655322005041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0196655322005041"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2022.06.019","relation":{},"ISSN":["0196-6553"],"issn-type":[{"value":"0196-6553","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and characteristics of multidrug-resistant Escherichia coli sequence type ST131 at two academic centers in Boston and Minneapolis, USA","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2022.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}